Mary Kom
As seen in:
India Times,
The Economic Times,
NDTV Sports,
Sportstarlive,
Outlook (India),
YourStory,
Pinkvilla,
Bollywood Hungama,
The Daily Check,
OUTSFL
and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Mary Kom
Inspired By Mary Kom, Suchika Tariyal Makes History With Asian Games MMA Bronze
"I can now die happily," an emotional Suchika Tariyal said on Monday after becoming India's first Asian Games medal winner in Mixed Martial Arts. The 36-year-old Suchika settled for a bronze in the women's traditional 60kg mixed martial arts event as Singapore's Hui Hoon Teo was awarded the semifinal on the basis of her lesser weight after the two fighters drew a fiercely-contested bout. "This is more than my life. I will never forget that I came to Japan and got a medal for my country.
Why the Florida Keys Are the Best Destination for Scuba and Snorkel Tours
The Florida Keys are the best destination for scuba and snorkel tours because they offer clear waters, vibrant marine life, accessible coral reefs, and year-round diving conditions that appeal to both beginners and experienced explorers. This combination of natural beauty and favorable conditions makes the region one of the top underwater destinations in the United States.
Why Victims Sometimes Choose Not to Press Charges
Choosing not to press charges is more common than many people realize, especially in sensitive situations like domestic violence. While it may seem surprising from the outside, victims often weigh emotional, financial, and personal factors before making this decision. In many cases, even when someone has been convicted of a domestic violence offense in the past, victims may still hesitate to move forward due to complex personal dynamics.
How to Find the Right Wrongful Death Attorney for Your Case
A sudden death caused by negligence is devastating. No amount of money can replace a loved one. Still, a wrongful death claim provides a safety net for surviving family members. Finding the right lawyer is the first step toward justice, so check their experience with these complex cases. The path through the courts is often confusing and draining for a grieving family. You might need to file a wrongful death lawsuit to recover costs for funerals, lost paychecks, and deep emotional pain.
What Married Buyers Need to Know About Florida Home Ownership
Buying a home in Florida as a married couple comes with a few key rules you should know upfront: state property laws, how ownership is titled, and what rights each spouse has all matter (sometimes more than the price of the home itself). Florida has unique protections for spouses, especially when it comes to primary residences, and those rules can affect everything from financing to selling later on. At first, the process may feel familiar. You find a home, secure a loan, and sign paperwork.
Sara Ali Khan on Metro… In Dino reminding her of Kedarnath; says, “I am really proud of myself” Original
Sara Ali Khan, who made a striking debut with Kedarnath in 2018, continues to be remembered for her raw and convincing performance in the film. The success of her first role set high expectations among audiences. Since then, Sara has explored a variety of characters—some well-received, others less so—but Kedarnath has remained a standout in her filmography.
Sidharth Malhotra and Kiara Advani blessed with a baby girl: Reports Original
Sidharth Malhotra and Kiara Advani have reportedly welcomed their first child, a baby girl, on Tuesday evening at HN Reliance (Reliance Foundation) Hospital in Girgaon. According to reports, both mother and newborn are doing well following a normal delivery. Sidharth Malhotra and Kiara Advani blessed with a baby girl: Reports Although the couple has yet to officially announce the birth, family and close friends are said to be overjoyed.
Triptii Dimri calls Dhadak 2 Siddhant Chaturvedi’s “best performance of his career”: “He has poured his heart and soul into the role” Original
Ever since the trailer for Dhadak 2 dropped, Siddhant Chaturvedi has been the centre of attention and rightfully so. His portrayal of Neelesh, a small-town boy caught between love, choices, and consequences, has struck a chord with audiences and critics alike.
Shekhar Kapur recalls eerie silence before Masoom became a hit: “They called it an ‘Article Film'”
In an industry driven by box-office numbers and opening weekend hysteria, few filmmakers would dare to recount the crushing silence of an empty theatre on their debut. But Shekhar Kapur is no ordinary filmmaker, and Masoom was no ordinary film.
“Vikram Bhatt is like family”: Priya Banerjee returns with thriller titled Heartbreaker
Priya Banerjee and Vikram Bhatt are back together for a gripping new drama titled Heartbreaker. The actress, who previously worked with the Bhatt banner on Rain and Twisted 3, believes the creative synergy she shares with the team continues to bring out her best. “Vikram Bhatt is like family”: Priya Banerjee returns with thriller titled Heartbreaker “Vikram Bhatt is like family. This is my third project with them and it’s always been a fantastic experience,” Priya says.
Vidya Balan shares thoughtful message on overcoming rejection: “I must have had great reserves of self-love” Original
Celebrated actor Vidya Balan struck a deep emotional chord with students at the 10th edition of India’s International Movement to Unite Nations (I.I.M.U.N.) “Role Model Series,” moderated by Rishabh Shah, founder of I.I.M.U.N held in Bandra. In a heartfelt and candid conversation, she spoke about embracing individuality, overcoming rejection, and the importance of self-love in an increasingly validation-seeking world.
“Sarzameen will always mark a turning point in my life,” says Kayoze Irani ahead of the release of his directorial debut
JioHotstar is set to premiere Sarzameen on July 25, 2025. The film features Prithviraj Sukumaran as Vijay Menon, a man navigating the complex responsibilities of being both a father and a soldier. Kajol stars as Meher, a mother striving to hold her family together, while Ibrahim Ali Khan portrays Harman, a young man dealing with inner conflict and divided loyalties.
Prabhas recalls K.G.F set fire incident, praises Hombale Films’ focus on quality: “Vijay Kiragandur said, ‘Don’t worry about the money'”
Prabhas, known for his pan-India appeal, has been part of several high-profile films including the Baahubali franchise, Adipurush, Salaar: Part 1 – Ceasefire, and Kalki 2898 AD.
POLL: Which of THESE 5 biographical films on Netflix left a lasting impact on you? Srikanth to Mary Kom; VOTE
Biographical dramas on Netflix showcase real-life stories of triumphs and struggles. From comebacks to achievements, which of these 5 biopics left the deepest impact? Vote now! Published on Mar 05, 2025 | 08:15 PM IST | 410 Biographical dramas bring real stories to life, showcasing the struggles and triumphs of extraordinary individuals, both famous and forgotten. With Netflix offering a diverse lineup, we polled viewers to see which films struck the deepest chord.
8th Edition Of 'Pariksha Pe Charcha' By PM Modi To Feature Deepika Padukone, Mary Kom, Sadhguru
National According to officials, in a shift from the traditional town hall format, Prime Minister Narendra Modi took 35 students to Sunder Nursery this year and interacted with them on a host of issues related to exams and stress management. Getting your Trinity Audio player ready...
Maverick helicopters announces aerial experiences for Formula 1 Las Vegas Grand Prix Week - Breaking News | Travel News
The post Maverick helicopters announces aerial experiences for Formula 1 Las Vegas Grand Prix Week appeared first on TD (Travel Daily Media) Travel Daily. Maverick Helicopters, will offer special flight experiences for the Formula 1 Heineken Silver Las Vegas Grand Prix. During race week, from Wednesday 15th to Saturday 18th November, Maverick Helicopters will provide premier aerial views of the Las Vegas Strip, race circuit and Grand Canyon.
What India should do to become a sporting superpower Original
Winds of change gather pace as India ascends in the global sports ecosystem. The legendary PT Usha is the first sportsperson to become the Chief of the Indian Olympic Association (IOA) in independent India’s history, as well as the first woman ever to hold this post. She is flanked by several olympians in the IOA and the first full fledged athletes commission.
In Wrestling Controversy, New Trouble Over Committee Headed By Mary Kom | Wrestling News
A day after the sports ministry formed an Oversight Committee, to probe allegations of sexual misconduct against Wrestling Federation of India (WFI) officials and to run the day-to-day affairs of the body, top wrestlers including Vinesh Phogat and Bajrang Punia tweeted that they were not consulted before forming the committee.
Wresters row, New Trouble Over Committee Headed By Mary Kom
ନୂଆଦିଲ୍ଲୀ: ଭାରତୀୟ କୁସ୍ତି ମହାସଂଘ ଅଧ୍ୟକ୍ଷ ବ୍ରିଜ ଭୂଷଣ ଶରଣ ସିଂଙ୍କ ନାଁରେ ଆସିଥିବା ଅଭିଯୋଗର ତଦନ୍ତ ପାଇଁ ଗଠିତ ନୀରିକ୍ଷଣ କମିଟି ଉପରେ ପ୍ରଶ୍ନ ଉଠିଛି । ଭାରତର ଷ୍ଟାର ରେସଲର ଭିନେଶ ଫୋଗାଟ, ବଜରଙ୍ଗ ପୁନିଆ ଏବଂ ସାକ୍ଷୀ ମଲ୍ଲିକ ଏହି କମିଟିକୁ ନେଇ ପ୍ରଶ୍ନ ଉଠଇଛନ୍ତି । ଭିନେଶ ଏବଂ ବଜରଙ୍ଗ ପୁନିଆ ଟ୍ୱିଟ୍ କରି ଅଭିଯୋଗ କରିଛନ୍ତି ଯେ, କମିଟି ଗଠନ କରାଯିବା ପୂର୍ବରୁ ସେମାନଙ୍କ ସହ କୌଣସି ଆଲୋଚନା କରାଯାଇ ନାହିଁ । ଉଲ୍ଲେଖଯୋଗ୍ୟ ଯେ ଭାରତୀୟ କୁସ୍ତି ମହାସଂଘ ଅଧ୍ୟକ୍ଷ ବ୍ରିଜ ଭୂଷଣ ଶରଣ ନାଁରେ ଆସିଥିବା ଯୌନ ନିର୍ଯାତନା ଅଭିଯୋଗର ତଦନ୍ତ ପାଇଁ କେନ୍ଦ୍ର ସରକାର ମେରୀ କମଙ୍କ ନେତୃତ୍ୱରେ ୫...
Tokyo Olympics: India's Results At A Glance On Day 3 (July 25) - A Medal-Less Day
India could not add on to their medal tally on Day 3 of Tokyo Olympics on Sunday. While the much-touted shooters failed for the second successive day, London 2012 boxing bronze medallist MC Mary Kom and Rio 2016 badminton silver medallist PV Sindhu made winning starts. Manika Batra advanced with an emphatic Round 2 win in table tennis but the day ended on a poor note when world champions Australia thrashed India 7-1 in a men's hockey pool match.
Have To Snap Out Of Modi’s 'Infallible Guru' Image: Jawhar Sircar, Ex Babu-Turned Mamata’s RS Nominee
Jawhar Sircar is not just any other bureaucrat. While serving as India’s culture secretary, he had earned a special kind of respect from the arts and culture world for himself for being a scholar and history buff with a sound knowledge of culture and religion. Since resigning from the post of CEO of Prasar Bharati in 2016, Sircar has emerged as one of the most vocal critics of the Modi government.
Watch: Girl Trying To Jump To Death Rescued At Faridabad Metro Station
The officers on duty at a metro station in Faridabad on Saturday rescued a girl who was trying to jump from the station building. A video of the incident has gone viral on the internet. According to reports, the girl, during the interrogation, told police that she wanted to end her life due to work-related stress. The incident happened at the Sector 28 metro station in Faridabad. In the video, the girl is seen sitting on the sidewall of the building and trying to jump.
Inspired By Mary Kom, World Championships Silver Medallist Manju Rani Is Punching Her Way To Glory
When Mary Kom started making a name for herself in boxing, she inspired several girls to take up what was pretty much considered a man's sport in India. One such girl is Manju Rani. Yes, Manju is just 20 but she is slowly making a name for herself in the boxing circuit. From humble beginnings she broke through the ranks to become the latest boxing sensation for India. She hails from Rithal Phogat village in the Rohtak district of Haryana. Her father was in the BSF who died of cancer in 2010.
Madrigal Pharmaceuticals (MDGL) Downgraded by ValuEngine
Posted by Mary Kom on Apr 18th, 2019 ValuEngine cut shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) from a strong-buy rating to a buy rating in a research note published on Monday, ValuEngine reports. Several other analysts have also issued reports on MDGL. Zacks Investment Research upgraded Madrigal Pharmaceuticals from a hold rating to a buy rating and set a $133.00 price objective for the company in a report on Wednesday, January 9th.
Myovant Sciences (MYOV) Upgraded to “Buy” at Zacks Investment Research
Posted by Mary Kom on Apr 18th, 2019 Myovant Sciences (NYSE:MYOV) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday, Zacks.com reports. The firm currently has a $22.00 price objective on the stock. Zacks Investment Research‘s price target would indicate a potential upside of 13.99% from the company’s previous close. According to Zacks, “Myovant Sciences Ltd. is a biopharmaceutical company.
Incyte (NASDAQ:INCY) Rating Lowered to Sector Perform at Royal Bank of Canada
Posted by Mary Kom on Apr 18th, 2019 Royal Bank of Canada lowered shares of Incyte (NASDAQ:INCY) from an outperform rating to a sector perform rating in a research report sent to investors on Wednesday, April 3rd, BenzingaRatingsTable reports. They currently have $89.00 price target on the biopharmaceutical company’s stock. The analysts noted that the move was a valuation call. Other analysts also recently issued research reports about the company.
YorkBridge Wealth Partners LLC Acquires 263 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Posted by Mary Kom on Apr 17th, 2019 YorkBridge Wealth Partners LLC increased its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) by 76.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 606 shares of the biotechnology company’s stock after purchasing an additional 263 shares during the period.
65,508 Shares in Sangamo Therapeutics Inc (SGMO) Purchased by Hsbc Holdings PLC
Posted by Mary Kom on Apr 17th, 2019 Hsbc Holdings PLC acquired a new position in Sangamo Therapeutics Inc (NASDAQ:SGMO) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 65,508 shares of the biopharmaceutical company’s stock, valued at approximately $752,000. Hsbc Holdings PLC owned about 0.06% of Sangamo Therapeutics at the end of the most recent quarter.
ZIOPHARM Oncology (ZIOP) Shares Down 6.5%
Posted by Mary Kom on Apr 18th, 2019 Shares of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) dropped 6.5% during trading on Wednesday . The stock traded as low as $4.11 and last traded at $4.15. Approximately 1,462,722 shares traded hands during trading, a decline of 14% from the average daily volume of 1,706,118 shares. The stock had previously closed at $4.44. Several brokerages recently weighed in on ZIOP.
Harvey Capital Management Inc. Has $5.87 Million Holdings in Celgene Co. (CELG)
Posted by Mary Kom on Apr 17th, 2019 Harvey Capital Management Inc. trimmed its stake in Celgene Co. (NASDAQ:CELG) by 23.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 62,227 shares of the biopharmaceutical company’s stock after selling 19,120 shares during the quarter. Celgene makes up about 2.8% of Harvey Capital Management Inc.’s portfolio, making the stock its 11th biggest holding.
Madrigal Pharmaceuticals Inc (MDGL) Shares Sold by Squarepoint Ops LLC
Posted by Mary Kom on Apr 17th, 2019 Squarepoint Ops LLC reduced its stake in Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) by 39.0% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 2,472 shares of the biopharmaceutical company’s stock after selling 1,579 shares during the quarter. Squarepoint Ops LLC’s holdings in Madrigal Pharmaceuticals were worth $279,000 at the end of the most recent quarter.
NVR, Inc. (NVR) Shares Bought by Retirement Systems of Alabama
Posted by Mary Kom on Apr 17th, 2019 Retirement Systems of Alabama boosted its holdings in NVR, Inc. (NYSE:NVR) by 0.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,755 shares of the construction company’s stock after acquiring an additional 20 shares during the period.
ZIOPHARM Oncology (ZIOP) Trading 5.2% Higher
Posted by Mary Kom on Apr 17th, 2019 ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) shares traded up 5.2% during trading on Tuesday . The stock traded as high as $4.50 and last traded at $4.44. 1,410,200 shares were traded during trading, a decline of 18% from the average session volume of 1,709,439 shares. The stock had previously closed at $4.22. Several research analysts have commented on the company. Lake Street Capital assumed coverage on ZIOPHARM Oncology in a research report on Thursday, April 4th.
Ionis Pharmaceuticals (IONS) Given a $75.00 Price Target by Piper Jaffray Companies Analysts
Posted by Mary Kom on Apr 16th, 2019 Piper Jaffray Companies set a $75.00 price target on Ionis Pharmaceuticals (NASDAQ:IONS) in a report released on Friday, March 22nd, The Fly reports. The brokerage currently has a neutral rating on the stock. A number of other research analysts also recently weighed in on the company. Zacks Investment Research downgraded Ionis Pharmaceuticals from a buy rating to a hold rating in a research note on Thursday, March 21st.
Editas Medicine (NASDAQ:EDIT) Raised to “Hold” at BidaskClub
Posted by Mary Kom on Apr 16th, 2019 Editas Medicine (NASDAQ:EDIT) was upgraded by stock analysts at BidaskClub from a “sell” rating to a “hold” rating in a report issued on Monday, April 1st, BidAskClub reports. Several other analysts have also recently weighed in on EDIT. Zacks Investment Research cut Editas Medicine from a “buy” rating to a “hold” rating in a research report on Wednesday, March 6th.
Incyte (INCY) and Protalex (PRTX) Head-To-Head Contrast
Posted by Mary Kom on Apr 16th, 2019 Incyte (NASDAQ:INCY) and Protalex (OTCMKTS:PRTX) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership. Profitability Get Incyte alerts: This table compares Incyte and Protalex’s net margins, return on equity and return on assets.
Mackay Shields LLC Invests $520,000 in ACADIA Pharmaceuticals Inc. (ACAD) Stock
Posted by Mary Kom on Apr 16th, 2019 Mackay Shields LLC acquired a new position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 32,205 shares of the biopharmaceutical company’s stock, valued at approximately $520,000. Other hedge funds and other institutional investors also recently modified their holdings of the company.
Amalgamated Bank Sells 710 Shares of Incyte Co. (INCY)
Posted by Mary Kom on Apr 16th, 2019 Amalgamated Bank reduced its stake in Incyte Co. (NASDAQ:INCY) by 2.7% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 25,813 shares of the biopharmaceutical company’s stock after selling 710 shares during the quarter. Amalgamated Bank’s holdings in Incyte were worth $1,641,000 at the end of the most recent reporting period.
Evercore ISI Begins Coverage on Intellia Therapeutics (NTLA)
Posted by Mary Kom on Apr 15th, 2019 Evercore ISI initiated coverage on shares of Intellia Therapeutics (NASDAQ:NTLA) in a research note published on Thursday morning, Benzinga’s Daily Ratings Newsletter reports. The firm issued an outperform rating on the stock. NTLA has been the subject of several other reports. BTIG Research started coverage on shares of Intellia Therapeutics in a research report on Thursday, February 7th. They set a buy rating and a $20.00 price objective for the company.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Two Sigma Advisers LP
Posted by Mary Kom on Apr 15th, 2019 Two Sigma Advisers LP reduced its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) by 22.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 72,004 shares of the biotechnology company’s stock after selling 20,900 shares during the quarter. Two Sigma Advisers LP’s holdings in BioMarin Pharmaceutical were worth $6,131,000 at the end of the most recent quarter.
Celgene Co. (CELG) Receives $98.42 Average Target Price from Brokerages
Posted by Mary Kom on Apr 14th, 2019 Shares of Celgene Co. (NASDAQ:CELG) have been given a consensus recommendation of “Hold” by the twenty-eight research firms that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, eighteen have issued a hold recommendation and nine have issued a buy recommendation on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $98.42.
Alkermes Plc (ALKS) Shares Sold by American International Group Inc.
Posted by Mary Kom on Apr 14th, 2019 American International Group Inc. cut its stake in Alkermes Plc (NASDAQ:ALKS) by 5.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,413 shares of the company’s stock after selling 410 shares during the period. American International Group Inc.’s holdings in Alkermes were worth $219,000 as of its most recent filing with the Securities and Exchange Commission.
Paloma Partners Management Co Invests $225,000 in Editas Medicine Inc (EDIT)
Posted by Mary Kom on Apr 14th, 2019 Paloma Partners Management Co acquired a new position in shares of Editas Medicine Inc (NASDAQ:EDIT) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 9,900 shares of the company’s stock, valued at approximately $225,000. A number of other institutional investors and hedge funds also recently modified their holdings of the stock.
Mackay Shields LLC Has $866,000 Holdings in Nektar Therapeutics (NASDAQ:NKTR)
Posted by Mary Kom on Apr 14th, 2019 Mackay Shields LLC lessened its holdings in shares of Nektar Therapeutics (NASDAQ:NKTR) by 19.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 26,337 shares of the biopharmaceutical company’s stock after selling 6,190 shares during the period. Mackay Shields LLC’s holdings in Nektar Therapeutics were worth $866,000 as of its most recent filing with the SEC.
Intrexon Corp (XON) Shares Sold by Commonwealth Equity Services LLC
Posted by Mary Kom on Apr 13th, 2019 Commonwealth Equity Services LLC reduced its holdings in shares of Intrexon Corp (NYSE:XON) by 6.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 66,336 shares of the biotechnology company’s stock after selling 4,732 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Intrexon were worth $433,000 at the end of the most recent quarter.
Ionis Pharmaceuticals Inc (IONS) SVP Sells $2,269,152.00 in Stock
Posted by Mary Kom on Apr 13th, 2019 Ionis Pharmaceuticals Inc (NASDAQ:IONS) SVP Patrick R. O’neil sold 28,800 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $78.79, for a total transaction of $2,269,152.00. Following the completion of the transaction, the senior vice president now owns 48,473 shares of the company’s stock, valued at $3,819,187.67.
ACADIA Pharmaceuticals Inc. (ACAD) Stake Lessened by California Public Employees Retirement System
Posted by Mary Kom on Apr 13th, 2019 California Public Employees Retirement System lowered its position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) by 9.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 106,100 shares of the biopharmaceutical company’s stock after selling 10,500 shares during the quarter.
Voloridge Investment Management LLC Takes $10.64 Million Position in Nektar Therapeutics (NKTR)
Posted by Mary Kom on Apr 12th, 2019 Voloridge Investment Management LLC bought a new stake in Nektar Therapeutics (NASDAQ:NKTR) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 323,645 shares of the biopharmaceutical company’s stock, valued at approximately $10,638,000. Voloridge Investment Management LLC owned 0.19% of Nektar Therapeutics at the end of the most recent quarter.
Hsbc Holdings PLC Has $1.63 Million Position in Nektar Therapeutics (NKTR)
Posted by Mary Kom on Apr 12th, 2019 Hsbc Holdings PLC cut its stake in Nektar Therapeutics (NASDAQ:NKTR) by 22.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 49,656 shares of the biopharmaceutical company’s stock after selling 14,260 shares during the quarter. Hsbc Holdings PLC’s holdings in Nektar Therapeutics were worth $1,632,000 at the end of the most recent quarter.
Richard S. Geary Sells 46,240 Shares of Ionis Pharmaceuticals Inc (IONS) Stock
Posted by Mary Kom on Apr 12th, 2019 Ionis Pharmaceuticals Inc (NASDAQ:IONS) SVP Richard S. Geary sold 46,240 shares of the firm’s stock in a transaction dated Monday, April 8th. The shares were sold at an average price of $84.01, for a total value of $3,884,622.40. Following the completion of the transaction, the senior vice president now owns 45,442 shares of the company’s stock, valued at approximately $3,817,582.42.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Mary
Contact Mary, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack